C
C

ConvaTec

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK Stocks-Factors to watch on Aug. 6

Aug 6 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 49 points lower at 6,056 on Thursday, according to financial bookmakers. * GSK: The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's GSK.L experimental treatment for a common form of blood cancer. * HOMEBUILDING: Britain will set out proposals to speed up home
A
A
B
B
C
E
G
G
H
I
M
P
S
S
R
U

UK Stocks-Factors to watch on Feb. 28

Feb 28 (Reuters) - Britain's FTSE 100 .FTSE index is down 3.3% on Friday. * LSE: The London Stock Exchange Group LSE.L said it would complete its $27 billion takeover of analytics company Refinitiv on time this year as it reported higher-than-expected annual income, driven a jump in clearing activity. * ROLLS-ROYCE: Aerospace engineer Rolls-Royce R
C
E
E
I
J
L
M
R

Moody's assigns Ba3 CFR to ConvaTec Group Plc; outlook stable

For the full text of this story please click the following link: Link
C
L

Top of the Street: European medical device & services sector, Electrocomponents

A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Peel Hunt cuts British industrial distribution company Electrocomponents ECM.L to "hold" from "add" due to its sales and margins looking set to slow down in H2 INITIATIONS AND REINSTATEMENTS ** Bernstein relaunches coverage of European medical device and servi
C
D
E
F
L
P
S
S

EU medical devices & services: Bernstein prefers companies dominant in their field

** Bernstein relaunches coverage European medical device & services sector with Phillips PHG.AS , Coloplast COLOb.CO , Smith & Nephew SNL.L , Siemens Healthineers SHLG.DE and Cochlear COH.AX , all "outperform", as to picks ** "As the global healthcare landscape evolves, in general we favour companies that are dominant in their field, as we believe
C
D
F
L
P
S
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.